TY - JOUR
T1 - Highly efficient cellular uptake of c-myb antisense oligonucleotides through specifically designed polymeric nanospheres
AU - Tondelli, Luisa
AU - Ricca, Alfredo
AU - Laus, Michele
AU - Lelli, Marco
AU - Citro, Gennaro
N1 - Funding Information:
The authors wish to thank Dr Anna Garbesi for continuous and helpful discussions. We also acknowledge the help of Dr Federica Sentinelli for experimental design and assistance, and Mrs Simona Righi for assistance in preparing the manuscript. This work was partially supported by grants from Associazione Italiana per la Ricerca sul Cancro, Consiglio Nazionale delle Ricerche (to G.C.). A.R. was supported by a fellowship from FIRC, Fondazione Italiana per la Ricerca sul Cancro.
PY - 1998/12/1
Y1 - 1998/12/1
N2 - c-myb antisense oligonucleotides (AS ODNs) were reversibly immobilized to a novel polymeric core shell nanosphere and their cellular uptake and inhibitory effect on HL60 leukemia cell proliferation studied. The nanosphere surface was so designed as to directly bind ODNs via ionic interactions and reversibly release them inside the cells. Compared with the cellular uptake of free oligonucleotide, the use of AS ODN (immobilized to the nanospheres) produced a 50-fold increase in the intracellular concentration. Specifically, a single dose of 320 nM of AS ODN immobilized to the nanospheres was capable of inhibiting HL60 cell proliferation with the same degree of efficiency obtained using a 50-fold higher dose of free AS ODN. Flow cytometric experiments with fluoresceinated ODNs showed a temperature-dependent uptake, which was detectable as early as 2 h after the beginning of treatment. The inhibitory effect on cell proliferation was maintained for up to 8 days of culture. Moreover, the level of c-Myb protein decreased by 24% after 2 days and by 60% after 4 days of treatment, thus indicating a continuous and sustained release of non-degraded AS ODN from the nanospheres inside the cells.
AB - c-myb antisense oligonucleotides (AS ODNs) were reversibly immobilized to a novel polymeric core shell nanosphere and their cellular uptake and inhibitory effect on HL60 leukemia cell proliferation studied. The nanosphere surface was so designed as to directly bind ODNs via ionic interactions and reversibly release them inside the cells. Compared with the cellular uptake of free oligonucleotide, the use of AS ODN (immobilized to the nanospheres) produced a 50-fold increase in the intracellular concentration. Specifically, a single dose of 320 nM of AS ODN immobilized to the nanospheres was capable of inhibiting HL60 cell proliferation with the same degree of efficiency obtained using a 50-fold higher dose of free AS ODN. Flow cytometric experiments with fluoresceinated ODNs showed a temperature-dependent uptake, which was detectable as early as 2 h after the beginning of treatment. The inhibitory effect on cell proliferation was maintained for up to 8 days of culture. Moreover, the level of c-Myb protein decreased by 24% after 2 days and by 60% after 4 days of treatment, thus indicating a continuous and sustained release of non-degraded AS ODN from the nanospheres inside the cells.
UR - https://www.scopus.com/pages/publications/0032404114
U2 - 10.1093/nar/26.23.5425
DO - 10.1093/nar/26.23.5425
M3 - Article
SN - 0305-1048
VL - 26
SP - 5425
EP - 5431
JO - Nucleic Acids Research
JF - Nucleic Acids Research
IS - 23
ER -